InvestorsHub Logo
Followers 1
Posts 45
Boards Moderated 0
Alias Born 08/16/2020

Re: None

Tuesday, 11/03/2020 3:01:44 PM

Tuesday, November 03, 2020 3:01:44 PM

Post# of 44690
If PhaseBio's VIP analogue didn't work out for them, why would Relief's?

I'm invested, and questioning like many others at this point. They just ended up dropping it. If VIP is an/the answer, then what gives?

It looks like 2 things happened: 1) difficulty w/enrollment and more importantly 2) not seeing evidence that it was worth pushing for expanded enrollment at this point.

https://www.businesswire.com/news/home/20201023005085/en/

Thoughts?